Literature DB >> 8354308

Epidemiology of invasive aspergillosis in European cancer centres. EORTC Invasive Fungal Infections Cooperative Group.

J Cohen, D W Denning, M A Viviani.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8354308     DOI: 10.1007/bf01964440

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

Review 1.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

Review 2.  Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host.

Authors:  D W Denning
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

3.  Fungal infections in cancer patients: an international autopsy survey.

Authors:  G Bodey; B Bueltmann; W Duguid; D Gibbs; H Hanak; M Hotchi; G Mall; P Martino; F Meunier; S Milliken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

4.  Restriction fragment length polymorphisms in isolates of Aspergillus fumigatus probed with part of the intergenic spacer region from the ribosomal RNA gene complex of Aspergillus nidulans.

Authors:  C L Spreadbury; B W Bainbridge; J Cohen
Journal:  J Gen Microbiol       Date:  1990-10

5.  Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin.

Authors:  D W Denning; K V Clemons; L H Hanson; D A Stevens
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

  5 in total
  7 in total

1.  Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

Authors:  K V Clemons; G Grunig; R A Sobel; L F Mirels; D M Rennick; D A Stevens
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.

Authors:  V Krcmery; E Kunova; Z Jesenska; J Trupl; S Spanik; J Mardiak; M Studena; E Kukuckova
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

Review 3.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Postmortem analysis of invasive aspergillosis in a tertiary care hospital.

Authors:  M Vogeser; A Haas; D Aust; G Ruckdeschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

5.  Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients.

Authors:  R Ansorg; E Heintschel von Heinegg; P M Rath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

6.  Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.

Authors:  J R Graybill; R Bocanegra; L K Najvar; D Loebenberg; M F Luther
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

Review 7.  Purine Acquisition and Synthesis by Human Fungal Pathogens.

Authors:  Jessica L Chitty; James A Fraser
Journal:  Microorganisms       Date:  2017-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.